46M-14866-50332
4 vaccinations
1 coded response
31 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 271 / NC
- Registered
- 2021-01-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
YZ4-80985-92606
Child or adolescent in my care · Female · 2022-10-18
Timeline
-
2020-12-23
Dose 1 — Pfizer-BioNTech
-
2021-01-15
Dose 2 — Pfizer-BioNTech
-
2021-01-16
Registered in v-safe
-
2021-01-16
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-16
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
- 2021-01-17
- 2021-01-18
- 2021-01-21
- 2021-01-22
- 2021-01-29
- 2021-02-05
- 2021-02-12
- 2021-02-26
- 2021-04-17
- 2021-07-16
-
2021-10-02
Dose 3 — Pfizer-BioNTech
- 2021-10-02
-
2021-10-03
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Nausea, DiarrheaAdult check-in
-
2021-10-04
Survey response — days 1–6 daily, dose 3MedDRA: Tachycardia — Feeling: Good · Fatigue or tirednessFree text: Low grade tachycardiaMedDRA releases: 2024-11 · check-in free text available
- 2021-10-06
- 2021-10-07
- 2021-10-08
- 2021-10-09
- 2021-10-16
- 2021-10-23
- 2021-11-02
- 2021-11-06
- 2021-11-13
- 2022-01-05
-
2022-10-07
Dose 4 — ModernaCo-administered: Flu
- 2022-10-18
- 2022-10-21
- 2022-10-30
- 2022-11-06
- 2022-11-20
- 2023-01-06
- 2023-04-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-23 | Pfizer-BioNTech | |
| 2 | 2021-01-15 | Pfizer-BioNTech | |
| 3 | 2021-10-02 | Pfizer-BioNTech | No |
| 4 | 2022-10-07 | Moderna | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-16 | priority 2/3 |
Free text
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Low grade tachycardia
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Tachycardia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release